Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Bausch Health (BHC) has a market cap of $1.67 billion USD. According to our data, Bausch Health is ranked No.4254 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.67 B |
-43.66%
|
| Dec 31, 2024 | $2.96 B |
0.50%
|
| Dec 29, 2023 | $2.95 B |
27.71%
|
| Dec 30, 2022 | $2.31 B |
-77.25%
|
| Dec 31, 2021 | $10.16 B |
32.74%
|
| Dec 31, 2020 | $7.65 B |
-30.48%
|
| Dec 31, 2019 | $11.00 B |
61.99%
|
| Dec 31, 2018 | $6.79 B |
-11.12%
|
| Dec 29, 2017 | $7.64 B |
43.11%
|
| Dec 30, 2016 | $5.34 B |
-85.72%
|
| Dec 31, 2015 | $37.39 B |
-28.97%
|
| Dec 31, 2014 | $52.64 B |
21.90%
|
| Dec 31, 2013 | $43.18 B |
96.42%
|
| Dec 31, 2012 | $21.98 B |
28.01%
|
| Dec 30, 2011 | $17.17 B |
65.04%
|
| Dec 31, 2010 | $10.41 B |
114.24%
|
| Dec 31, 2009 | $4.86 B |
56.21%
|
| Dec 31, 2008 | $3.11 B |
-19.22%
|
| Dec 31, 2007 | $3.85 B |
-29.65%
|
| Dec 29, 2006 | $5.47 B |
-8.55%
|
| Dec 30, 2005 | $5.98 B |
46.67%
|
| Dec 31, 2004 | $4.08 B |
-23.08%
|
| Dec 31, 2003 | $5.30 B |
-18.63%
|
| Dec 31, 2002 | $6.52 B |
-53.05%
|
| Dec 31, 2001 | $13.88 B |
44.82%
|
| Dec 29, 2000 | $9.58 B |
65.72%
|
| Dec 31, 1999 | $5.78 B |
147.93%
|
| Dec 31, 1998 | $2.33 B |
-3.20%
|
| Dec 31, 1997 | $2.41 B |
52.44%
|
| Dec 31, 1996 | $1.58 B |
-0.49%
|
| Dec 29, 1995 | $1.59 B |
836.36%
|
| Dec 30, 1994 | $0.17 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
| Market Cap | = | BHC Stock Price | * | BHC Shares Outstanding |
| = | $4.52 | * | 0.37 B | |
| = | $1.67 B |